60 DEGREES PHARMACEUTICALS, INC.
Last · NASDAQ$0.9768+0.0578 (+6.29%)live · yahoo · 3h ago
MA10MA20MA50
Market cap$3.44M3.5M sh
P/E · TTM-0.4fwd -0.3 · eps -2.67 · loss
Beta2.54vs S&P 500
Div yield—annual · TTM
52w range
$0.897$8.62
Volume82.0Ksession
Issuer
Legal name60 DEGREES PHARMACEUTICALS, INC.
HQUnited States (US)
ListingUS SXTP
ISINUS83006G5009
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001946563
CIK0001946563
Websitewww.60degreespharma.com
Employees3
Address60 Degrees Pharmaceuticals, Inc. 1025 Connecticut Avenue NW 20036, Washington
Loading chart…
Press & signals
- GlobeNewswire
60 Degrees Pharmaceuticals Announces Second Quarter 2026 Results
- GlobeNewswire
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules
- Satelight
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright
The rest of this company's wire — with summaries and source links — is part of Pro.
See plansDocuments
FormReporting forFiledFlags
Showing 5 of 56 filings